The Latest Breaking News from Moderna

It’s yet another sign that while the official pandemic state may be over, the days of COVID are far from it.

The virus sometimes causes severe illness even in those without underlying conditions, including deaths in children

Moderna plans on investing $25 billion in research and development from 2024 through 2028.

Moderna said Wednesday its flu shot outperformed broadly used vaccines from Sanofi and GSK. The results bolstered Moderna stock.

An updated Coronavirus booster that targets a new variant is expected to be made available in September

US president’s message comes after CDC and FDA decide to recommend Covid booster shots amid rising cases

On Sept. 12, 2023, the Centers for Disease Control and Prevention recommended the newly formulated COVID-19 vaccines for all Americans ages 6 months and up, hours after its expert advisory committee voted 13 to 1 in favor of recommending the vaccines.

Chicago public health officials have said the CDC approval was all they needed to “begin the rollout” of the vaccine, which will be free for all city residents. “We already have the vaccine in Chicago,” Dr. Geraldine Luna, medical director for the Chicago Department of Public Health, said Monday.

Americans may soon be able to get an updated COVID-19 vaccine

Lower-income countries did not get the COVID vaccines they needed. So the World Bank and other partners tapped a South African company to cook up the (undisclosed) recipe for the Moderna mRNA vaccine.

The CDC anticipates having adequate supply and shouldn’t need to prioritize certain groups, like the elderly or immunocompromised, for first doses, officials said at a Tuesday committee meeting.